Gefitrust Tablet

Introduction to Gefitrust Tablet

The Gefitrust Tablet is a medication primarily used to treat a specific type of lung cancer known as non-small cell lung cancer (NSCLC). It is particularly effective for patients with certain gene mutations called EGFR mutations. This tablet is usually prescribed to patients who have not undergone prior chemotherapy.

Composition of Gefitrust Tablet

The active ingredient in the Gefitrust Tablet is Gefitinib, which is an EGFR tyrosine kinase inhibitor. This means it works by blocking signals that promote cancer cell growth, specifically targeting the mutated EGFR receptors.

Uses of Gefitrust Tablet

• Treatment of locally advanced non-small cell lung cancer (NSCLC)
• Treatment of metastatic non-small cell lung cancer (NSCLC)
• Specifically for patients with EGFR mutations

Side effects of Gefitrust Tablet

Common side effects:

• Diarrhea
• Skin rash
• Nausea
• Vomiting
• Loss of appetite

Serious side effects:

• Liver toxicity
• Lung inflammation
• Severe diarrhea leading to dehydration

Precautions of Gefitrust Tablet

Gefitrust Tablet should not be taken by individuals without EGFR mutations, pregnant or breastfeeding women, or those with severe liver or kidney disease. It is also contraindicated for patients with a history of interstitial lung disease or those allergic to Gefitinib or any of its ingredients.

How to Take Gefitrust Tablet

• Take one tablet orally once daily.
• It is best to take it at the same time each day.
• Swallow the tablet whole with water.
• Do not crush or chew the tablet.

Conclusion of Gefitrust Tablet

The Gefitrust Tablet is a targeted therapy for certain types of lung cancer, offering hope to patients with specific genetic profiles. While it can be highly effective, it is important to be aware of potential side effects and take necessary precautions. Always consult with a healthcare provider to ensure it is the right treatment for you.